Dominican Republic vs Lebanon: Access to anti-retroviral drugs, female
Dominican Republic
68.0%
in 2024
Lebanon
69.0%
in 2024
Dominican Republic rank
86th
Lebanon rank
84th
Access to anti-retroviral drugs, female over time
- Dominican Republic
- Lebanon
How they compare
Lebanon currently reports 69.0% against 68.0% in Dominican Republic, a difference of 1.0%.
Across all 25 years both countries report, Lebanon has been ahead every year.
Dominican Republic ranks 86th and Lebanon ranks 84th of 141 countries.
Lebanon has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Dominican Republic | Lebanon | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 5.1% | 16.4% | 11.3% | Lebanon |
| 2010s | 35.0% | 42.5% | 7.5% | Lebanon |
| 2020s | 60.4% | 66.8% | 6.4% | Lebanon |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Dominican Republic or Lebanon?
- Lebanon, at 69.0% against 68.0% in Dominican Republic as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Dominican Republic and Lebanon?
- 1.0%, with Lebanon ahead.
- How many years of comparable data are there for Dominican Republic and Lebanon?
- 25 years are reported by both, from 2000 to 2024.
- How do Dominican Republic and Lebanon rank globally for access to anti-retroviral drugs, female?
- Dominican Republic ranks 86th and Lebanon ranks 84th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.